INTRODUCTION
Common genetic polymorphisms predispose to complex diseases such as type I diabetes, multiple sclerosis, Crohn's disease, and ulcerative colitis (The Wellcome Trust Case Control Consortium, 2007; Altshuler et al., 2008) . It is not clear why some individuals with a given polymorphism acquire disease whereas others remain unaffected. The concept that environmental factors including infections trigger disease in individuals with certain genetic backgrounds is broadly recognized. In animal models, autoimmune disease can be influenced by viral infections. For example, glomerulonephritis is exacerbated by lymphocytic choriomeningitis virus and polyoma virus infections in certain inbred backgrounds (Tonietti et al., 1970) , and lymphocytic choriomeningitis virus infection inhibits development of diabetes in NOD mice or BB rats (Dyrberg et al., 1988; Oldstone, 1988) . The genes responsible for these differences in outcome have not been defined, but these studies indicate that virus infection can alter disease in specific genetic backgrounds.
Crohn's disease is a common type of inflammatory bowel disease involving mucosal ulceration and inflammation occurring in the distal small intestine (ileum) and variable discontinuous regions of the colon. A distinguishing feature of inflammation in Crohn's disease is involvement of the entire thickness of the bowel wall. This transmural inflammation leads to atrophy of ileal villi, fibrosis, hypertrophy of smooth muscle and autonomic nerve cells in the outer layer of the bowel wall, and an inflammatory response including lymphoid aggregates and granulomas (Day et al., 2003) . Polymorphisms in over 30 loci have been associated with increased risk of Crohn's disease (Barrett et al., 2008 ). Yet these genetic components individually, or in combination (Weersma et al., 2008) , confer limited risk. Environmental factors such as exposure to pathogens are potential cofactors for disease development, but the etiology of Crohn's disease remains a controversial topic (Packey and Sartor, 2009) .
One Crohn's disease susceptibility allele is in the autophagy gene ATG16L1 (The Wellcome Trust Case Control Consortium, 2007; Rioux et al., 2007; Hampe et al., 2007) . The ATG16L1 disease variant is frequent ($50% in European-derived populations) and confers less than a 2-fold increase in susceptibility. We previously established two mouse lines in which Atg16L1 expression is disrupted by gene trap mutagenesis (Cadwell et al., 2008a) . Mutant mice displayed hypomorphic (HM) Atg16L1 protein expression and reduced autophagy (Cadwell et al., 2008a; Ju et al., 2009) . Conventionally raised Atg16L1 HM mice display striking abnormalities in Paneth cells, epithelial cells at the base of ileal crypts that are important in mucosal immunity (Porter et al., 2002; Ouellette, 2006; Vaishnava et al., 2008) . In addition to aberrant packaging and exocytosis of antimicrobial granules, Paneth cells from Atg16L1 HM mice display a surprising gain-of-function transcriptional profile in which transcripts associated with lipid metabolism, proinflammatory cytokines, and other pathways were enriched. Importantly, we observed similar Paneth cell abnormalities in Crohn's disease patients homozygous for the risk allele of ATG16L1 but not in control patients (Cadwell et al., 2008a) . Therefore, these aspects of intestinal pathology link Crohn's disease patients carrying the susceptibility allele of ATG16L1 to mice that are hypomorphic for Atg16L1.
Here, we report a striking genetic interaction between Atg16L1 mutation and a specific strain of an enteric virus, murine norovirus (MNV). This interaction determines multiple pathologic abnormalities in the intestine including several similar to those observed in Crohn's disease patients. Noroviruses are positivesense encapsidated RNA viruses responsible for the majority of epidemic nonbacterial gastroenteritis in humans (Mead et al., 1999) . Multiple strains of MNV are prevalent in mouse facilities around the world (Hsu et al., 2005; Pritchett-Corning et al., 2009; Goto et al., 2009) , and some MNV strains persist for months after initial infection (Thackray et al., 2007) . We demonstrate that Paneth cell abnormalities in Atg16L1 HM mice are triggered by infection with an MNV strain that establishes persistent infection (persistent strain). This virus-plus-susceptibility gene interaction alters the transcriptional signature of Paneth cells and the nature of the inflammatory response in mice treated with the toxic substance dextran sodium sulfate (DSS). The mechanism for this pathologic response driven by the virus-plus-susceptibility gene interaction involved the cytokines TNFa and IFNg as well as commensal bacteria. Our results provide evidence for a multi-hit model of inflammatory disease defined in a highly specific way by a viral infection only in the presence of a mutation in a disease susceptibility gene. This observation provides a basis for understanding how a common allele can be linked to an infrequent severe disease, and why mice carrying mutations in human disease susceptibility genes do not always spontaneously reproduce human pathology.
RESULTS

Viral Infection Triggers Paneth Cell Abnormalities in Atg16L1
HM Mice Atg16L1 HM mice raised in a conventional barrier facility were rederived into an enhanced barrier facility (Experimental Procedures) by embryo transfer. Surprisingly, in contrast to observations made in mice from a conventional barrier (Cadwell et al., 2008a) , Paneth cells in rederived Atg16L1 HM mice were indistinguishable morphologically from those in littermate wild-type control mice (herein referred to as WT) ( Figure 1A ) and failed to display aberrant packaging of the granule protein lysozyme ( Figure 1B ). All subsequent experiments were performed in mice raised in the enhanced barrier facility.
These results suggest that Paneth cell abnormalities require an exogenous factor present in the conventional barrier facility. We previously identified the first murine norovirus (MNV) in mice from this facility (Karst et al., 2003) . We therefore considered the possibility that MNV triggers Paneth cell abnormalities in Atg16L1 HM mice. To test this, mice were orally inoculated with an MNV strain that establishes persistent infection (MNV CR6) (Thackray et al., 2007) . Seven days postinoculation, Atg16L1 HM but not WT mice displayed Paneth cell abnormalities including aberrant granule numbers, size, and distribution (Figure 1A) . UV-inactivated virus did not induce these abnormalities ( Figure S1A , available online) indicating that productive virus infection was required. MNV CR6 infection for 7 days also induced abnormal lysozyme distribution and abnormal ultrastructural morphology in Paneth cells from Atg16L1 HM mice ( Figure 1B and Figures S1B and S1C). We used a previously established scale to blindly identify cells with increasingly abnormal lysozyme staining (Figure 1C ) (Cadwell et al., 2008a) . Only Atg16L1 HM mice that were infected with MNV CR6 displayed Paneth cells with the two most severe abnormalities ( Figure 1D ). Analysis of Paneth cells by transmission electron microscopy also revealed a substantial proportion of cells that were depleted of secretory granules in MNV CR6-infected Atg16L1 HM mice (Figures S1B and S1C). Moreover, many of the Paneth cells from these mice contained distended rough endoplasmic reticulum (Figures S1B and S1C). Other cytoplasmic organelles including mitochondria were not obviously altered in virally-infected Atg16L1 HM mice.
Thus, Paneth cell morphological and granule packaging abnormalities were induced by the combination of viral infection and mutation in the Crohn's disease susceptibility gene Atg16L1. Hereinafter we will refer to this as a virus-plus-susceptibility gene interaction.
Properties of MNV Associated with Paneth Cell Abnormalities
Since autophagy is important in innate immunity (Virgin and Levine, 2009 ), a mutation in Atg16L1 might lead to enhanced viral replication and cytopathicity in Paneth cells. When comparing WT and Atg16L1 HM mice, we did not observe significant differences in viral shedding in the stool or viral titers in organs including the distal ileum where Paneth cell abnormalities were observed ( Figure S2A ). Consistent with a previous report in which MNV was detected in the lamina propria (Mumphrey et al., 2007) , we did not detect MNV in Paneth cells by immunohistochemistry, and viral RNA was not detected in Paneth cell RNA procured by laser capture microdissection (data not shown, Experimental Procedures). Thus, direct infection of Paneth cells is not responsible for triggering the abnormalities described above.
To determine if Paneth cell abnormalities develop after infection with any virus, we investigated MNV CW3 that does not persist in immunocompetent mice despite sharing 95% amino acid sequence identity across the genome with MNV CR6 (Mumphrey et al., 2007; Thackray et al., 2007) . As in WT mice, shedding of MNV CW3 in Atg16L1 HM mice is initially high but reduced or undetectable at later time points ( Figure S2B ). MNV CW3 failed to trigger aberrant Paneth cell morphology 7 days postinfection ( Figure 2A ). Whereas MNV CW3 induced some changes in lysozyme distribution (increase in D 2 ), the most abnormal distribution pattern (D 3 ) was not detected (Figure 2B ). Since the lysozyme staining pattern seen after MNV CW3 infection was similar in both WT and Atg16L1 HM mice, these mild changes may constitute a normal response to viral infection. Nevertheless, induction of Paneth cell abnormalities specific to Atg16L1 HM mice is virus strain-dependent and associated with viral persistence, a property of MNV CR6 but not MNV CW3. Since MNV CW3 shedding is reduced or undetected 7 days postinfection, we also evaluated lysozyme distribution at day 3 postinfection when viral shedding is high. The majority of Paneth cells were normal (D 0 pattern; Figure S2C (Cadwell et al., 2008a) .
To determine if gene expression is influenced by the virus-plussusceptibility gene interaction, we compared gene expression in Paneth cells from WT and Atg16L1 HM mice 7 days after infection with MNV CR6 (Figure 3 ). Data were analyzed from three biological replicate experiments. Among genes whose expression were increased or decreased at least 1.5-fold (p < 0.05) in response to MNV infection, 39 were shared between WT and Atg16L1 HM mice (Zones C and F in Venn diagram, Figure 3 ). Of these, 27 exhibited expression changes of similar magnitude and in the same direction in WT and Atg16L1 HM mice ( Figure S3 ). with MNV CR6 (n > 5,700 cells from 3 mice/condition, *p < 0.05, **p < 0.01, ***p < 0.001, mean ± SEM). See also Figure S1 .
We next identified gene expression changes attributable to virus-plus-susceptibility gene interaction employing a factorial design approach incorporating ''differential-of-differential'' analysis that examined factor combinations of the two experimental dimensions (infection states and genotypes). Seven hundred fifty-nine genes were altered differentially between the two genotypes as a result of MNV CR6 infection (Zones A-D in Venn diagram, Figure 3 ). Enrichment analysis of these genes identified a significant overrepresentation of the biological processes of intracellular protein traffic, protein targeting and localization, and amino acid metabolism ( Figure 3 ). These results are consistent with autophagy deficiency and Paneth cell ER and granule packaging abnormalities observed in virally-infected Atg16L1 HM mice ( Figure 1 and Figures S1B and S1C). We also identified transcripts that were not significantly altered in response to infection within a genotype, but displayed significant expression differences between genotypes (Zone A in Venn diagram, Figure 3 ). These transcripts were enriched for those encoding transporters and ligases, particularly those involved in processing ubiquitin. Figure S4 ). Of these, 2181 were unique to MNV CW3 compared to MNV CR6 infection. Enrichment analyses of the MNV CR6 and CW3 data sets supported the virus strain-specific nature of this effect; there was no overlap in significantly enriched functional groups ( Figure S4 ).
Virus-Plus-Susceptibility Gene Interaction Generates an Aberrant Intestinal Injury Response
Since changes in Paneth cells depended on a virus-plussusceptibility gene interaction, intestinal responses to an additional environmental ''hit'' might also be influenced by this interaction. Administration of dextran sodium sulfate (DSS) induces intestinal injury. We chose a concentration of DSS (2.5%) that causes mild pathology and no lethality 7 days posttreatment in immunocompetent mice. Instead, this treatment induces a reproducible programmed response in immunocompetent mice including decreased epithelial cell proliferation, loss of epithelial integrity, and generation of ulcers in specific colonic regions (Pull et al., 2005) . As expected, uninfected Atg16L1 HM and both uninfected and MNV CR6-infected WT mice fed DSS developed a typical response including focal ulcers in the transverse colon and a single confluent ulcer adjacent to the ano-rectal junction, whereas the ileum was not ulcerated ( Figure 4A ). Thus, Atg16L1 mutation alone does not lead to altered responses to DSS-induced intestinal injury.
Remarkably, Atg16L1 HM mice infected with MNV CR6 for 1 week prior to DSS treatment exhibited aberrant responses to injury in the colon (Figure 4) . In ulcers adjacent to the ano-rectal junction, infected Atg16L1 HM mice unexpectedly exhibited multiple hallmarks of human Crohn's disease including increased inflammation in the muscularis and associated mesenteric fat and blood vessels, increases in lymphoid aggregates, development of subserosal fibrosis, hypertrophy of the muscularis propria, and hyperplasia of the proximal epithelium (Figure 4 ). These aspects of intestinal pathology in our experimental system were similar to the typical intestinal pathology of Crohn's disease patients (Roberts, 2009 ). Thus, virus-plus-susceptibility gene interaction resulted in a significantly altered intestinal injury response.
In contrast to MNV CR6, infection of Atg16L1 HM mice with the nonpersistent strain MNV CW3 did not induce inflammatory hallmarks of Crohn's disease after DSS treatment ( Figures 4C  and 4D ). Further, Atg16L1 HM mice receiving MNV CR6 and DSS concurrently did not develop inflammatory hallmarks of Crohn's disease and were indistinguishable from similarly treated WT mice ( Figures 4C and 4D ). In contrast, Atg16L1 HM mice infected with MNV CR6 for 28 days before DSS treatment developed similar inflammatory pathologies to those seen 7 days after infection (data not shown). These data are consistent with a role for viral persistence. Taken together, these results indicate that in the context of DSS treatment, virus strain specificity and timing of infection are important factors in virus-plussusceptibility gene interaction.
Unexpected Ileal Pathology Dependent on Virus-Plus-Susceptibility Gene Interaction Atg16L1 HM mice infected with MNV CR6 prior to DSS administration displayed ileal pathology not previously reported in DSS-treated mice. In contrast to WT mice, Atg16L1 HM mice receiving DSS exhibited virus-dependent mucosal atrophy manifested as blunting of villi ( Figure 5 ) similar in degree to that observed in Crohn's disease (Roberts, 2009) , celiac disease (Chand and Mihas, 2006) , or human norovirus-induced gastroenteritis (Agus et al., 1973; Dolin et al., 1975 MNV CR6 infection. Venn diagram displays the subsets of genes found to be differentially expressed (p < 0.05 as defined using a linear model and exhibiting a fold-change > 1.5) in the respective comparisons as indicated (circles 1 to 3). The ''differential-of-differential'' analysis in the factorial design identified genes that respond differently to infection in Atg16L1 HM mice compared to WT mice (Zones A, B, C, and D bounded by the red circle). These were found to be enriched for genes associated with intracellular protein traffic, protein targeting and localization, and amino acid metabolism. Also noteworthy is the sizable representation of genes associated with carbohydrate metabolism. The expression profiles for genes in these biological process categories are displayed as Log 2 -transformed fold-changes in the heat maps. The ''differential-of-differential'' analysis also identified genes that were not significantly altered in response to infection when compared within each genotype but exhibited significant differences when comparing responses to infection between genotypes as highlighted in Zone A. Genes with transporter functions or those with ligase activity were significantly enriched in this subset. See also Figures S3 and S4 .
Figure 5B). MNV CR6 infection for 1 week prior to DSS administration was required for induction of villus blunting ( Figure 5B ).
One explanation for aberrant DSS-induced pathologies observed in virus-infected Atg16L1
HM mice would be uncontrolled viral replication. However, there were no significant differences in viral replication in the ileum and colon where aberrant pathology is observed prior to or after DSS treatment ( Figures  S2A and S5 ). Less MNV CR6 was detected in the mesenteric lymph nodes from Atg16L1 HM compared to WT mice receiving DSS, indicating that virus-plus-susceptibility gene effects were not mediated by increased viral replication.
TNFa, IFNg, and Commensal Bacteria Mediate Intestinal Injury Responses Dependent on Virus-Plus-Susceptibility Gene Interaction
To identify mediators of DSS-induced pathology dependent on virus-plus-susceptibility gene interaction, we examined the role of cytokines. TNFa is a major mediator of inflammation in Crohn's disease; administration of blocking antibodies that interfere with with MNV CR6 for 7 days or uninfected, and subsequently given 2.5% DSS for an additional 7 days at which point intestines were harvested. Light microscopy images of H&E stained sections of ulcerated regions located immediately adjacent to the ano-rectal junction are shown. Yellow double-headed arrows indicate the muscularis propria thickness. In the MNV CR6-infected Atg16L1 HM sample, lymphoid aggregates are indicated by yellow dashed circles, and the black dashed region contains submucosal fibrosis and inflammation. Scale bar represents 500 mm.
(B) Table summarizing the outcome of DSS treatment. All intestines were harvested at the end of DSS treatment for analysis. + and À refer to the presence or absence of inflammatory hallmarks of Crohn's disease respectively (n R 6 mice/ condition).
(C) Quantification of the muscularis propria thickness in the region adjacent to the ano-rectal junction from DSS-treated mice. Seven days and 0 days refer to the amount of time mice were inoculated with the virus prior to DSS treatment. The increase in muscle thickness was normalized to the average of uninfected WT mice treated with DSS (*p < 0.05, ***p < 0.001, mean ± SEM).
(D) Number of lymphoid aggregates in the region adjacent to the ano-rectal junction from DSStreated mice (***p < 0.001, mean ± SEM). N.D. refers to not detected. See also Figure S5 .
TNFa signaling is a powerful therapeutic approach (Targan et al., 1997) . Furthermore, excess TNFa induces villus blunting as observed in Figure 5 (Piguet et al., 1999) . Upon in vitro stimulation, intestinal lymphocytes from Crohn's disease patients secrete increased IFNg (interferon-g) (Fuss et al., 1996; Fais et al., 1991) , which can function in concert with TNFa in inflammatory processes (Suk et al., 2001; Lake et al., 1994) , and IFNg may have a role in DSS-induced intestinal injury (Brem-Exner et al., 2008) .
MNV CR6-infected, DSS-treated Atg16L1 HM mice given TNFa or IFNg blocking antibodies displayed dramatically reduced muscular hypertrophy, fewer lymphoid aggregates adjacent to the ano-rectal junction, and decreased ileal villus blunting ( Figures 6A-6C) . Importantly, only the pathologies specific to virally-infected Atg16L1 HM mice were altered as blocking antibodies had no effect on the superficial ulceration typical of DSS treatment present in all conditions. Thus, TNFa and IFNg were each necessary for the DSS-induced pathologies in both ileum and colon that were dependent on virus-plus-susceptibility gene interaction.
Commensal bacteria are important in inflammatory bowel disease (Sartor, 1997; Kang et al., 2008) , and there is precedence for a role of bacteria in disease triggered by viral infection as in secondary infection with Streptococcus pneumoniae after influenza (McCullers, 2006) . To determine if the intestinal injury response dependent on virus-plus-susceptibility gene interaction requires commensal bacteria, Atg16L1 HM mice were infected with MNV CR6 and treated with both DSS and broad spectrum antibiotics. Antibiotics uptake was similar across groups and did not interfere with the administration of DSS (Extended Experimental Procedures). Administration of antibiotics to virally-infected Atg16L1 HM mice prevented abnormal DSS-induced pathologies in both ileum and colon reported above ( Figures 6D-6F) . Thus, aberrant injury responses dependent on virus-plus-susceptibility gene interaction require commensal bacteria.
DISCUSSION
An important goal is to identify specific genetic, infectious, or environmental factors responsible for a given disease. When such an etiologic smoking gun is detected, the full power of medicine, chemistry, and vaccine development can be brought to bear on the illness. However, if complex diseases are combinatorial in etiology, then an individual gene or pathogen may display only poor association with disease incidence and severity. This model of complex disease is widely recognized but experimental evidence has not been reported.
In this study, we define a complex inflammatory disease in mice that depends on an interaction between a specific enteric virus strain and a single host disease susceptibility gene. Several of the pathologic features observed in this model resemble those in many Crohn's disease patients. In particular, Paneth cell structural and granule packaging abnormalities observed in virus-infected Atg16L1 HM mice are remarkably similar to those in patients homozygous for the risk allele of ATG16L1. Since Crohn's disease patients homozygous for the nonrisk allele of ATG16L1 do not display this pathology, virus-plus-susceptibility gene interaction may contribute to heterogeneity between patients. Importantly, Paneth cells from Atg16L1 HM mice infected with virus have a fundamentally different gene expression profile than controls. These results provide a specific example of how a genetic factor and an environmental agent, each innocuous by itself, can have profound effects on the host when combined. These results also provide one explanation for why persons in clinical trials may display widely variable responses to treatment for a single pathologically defined disease.
Mechanisms of Pathology Induced by Virus-Host Susceptibility Gene Interaction
Despite the importance of autophagy genes in regulating the intracellular replication of pathogens, Atg16L1 mutant mice did not display increased MNV replication, virus was not detected in Paneth cells, and we found no role for Atg16L1 in control of MNV replication in vitro using primary macrophages from Atg16L1 HM mice (data not shown). In this context, it is interesting that Paneth cell abnormalities, the transcriptional response to infection, and DSS-induced pathologies were dependent on infection with MNV CR6, a strain capable of persistent infection. Notably, the two strains of MNV used in this study generate serologically indistinguishable antibody responses (Thackray et al., 2007) despite the dramatic difference in ability to induce disease in Atg16L1 mutant mice. Additionally, aberrant DSS-induced pathologies were dependent on the timing of MNV infection. The relationship between an infectious agent and a complex disease is typically established through serology or the presence of a pathogen in infected tissue. These conventional approaches may dismiss etiologic agents if the disease is dependent on a specific pathogen strain or the timing of the infection. Detection of virus-plus-susceptibility gene interactions in humans may therefore require advances in the capacity to identify viruses present in tissues in an unbiased way, allowing a better understanding of the relationship between the human virome and disease pathogenesis . To be revealing, such studies will have to be coupled to high power epidemiological studies and analysis of when patients were exposed to environmental factors. The aberrant intestinal injury response we described in virally-infected Atg16L1 HM mice was dependent on three factors associated with Crohn's disease pathogenesis in humansTNFa, IFNg, and commensal bacteria. This common role of two cytokines and commensal bacteria suggest that the human disease and the observed pathologies in mice share an underlying mechanism, and supports the relevance of the virusplus-susceptibility gene interaction reported here. Consistent with the efficacy of TNFa and IFNg blockade in our model, cytokine-mediated injury after viral infection is receiving attention as an attractive target for therapeutic intervention (Marsolais et al., 2009; Brockman et al., 2009 ). There is also evidence for an intersection between viral infection and commensal bacteria (Brenchley et al., 2006; Xi et al., 2008) . The antibiotic responsiveness of the DSS-induced disease in our model reveals an Seven days and 0 days refer to the amount of time mice were inoculated with the virus prior to DSS treatment (an average of 286 total villi from at least 5 mice/condition was measured, **p < 0.01, ***p < 0.001, mean ± SEM). See also Figure S5 .
important bacterial component to the virus-plus-susceptibility gene interaction that may be exploited therapeutically. The gene expression and morphological changes in Paneth cells we report are consistent with an important role of Atg16L1 in the secretory pathway and the response of epithelial cells to infection. These functions of Atg16L1 may be related to the membrane trafficking component of autophagy. Consistent with a cell autonomous role of Atg16L1 in Paneth cells, intestinal epithelium-specific deletion of two other autophagy genes also leads to Paneth cell granule defects (Cadwell et al., 2008a; Cadwell et al., 2008b) . Since Atg16L1 and its binding partner Atg5 can limit cytokine production (Saitoh et al., 2008; Jounai et al., 2007; Tal et al., 2009 ), viral infection may trigger an altered cytokine response in Atg16L1 mutant mice. Although the changes we see are in the epithelium, the complex inflammatory phenotype reported here may also depend on Atg16L1 function in other cell types. For example, the necessity of autophagy genes for T-cell function (Pua et al., 2007; Nedjic et al., 2008) may be relevant given the role of T cells in colitis after adoptive transfer into Rag2-deficient mice (Barnes and Powrie, 2009) ; the role of MNV has not been explored in that model.
It is tempting to speculate that Paneth cell abnormalities contribute to aberrant DSS-induced pathologies. Local production of inflammatory molecules by Paneth cells may drive villus blunting in the ileum. Moreover, virally-infected Atg16L1 HM mice can have alterations in commensal bacteria since mice with Paneth cells that have lost a-defensin activation develop intestinal dysbiosis including the emergence of segmented filamentous bacteria (Salzman et al., 2010 ) that stimulate the development of Th17 lymphocytes (Ivanov et al., 2009) . Paneth cells are not present in the mouse colon where viral infection alters injury responses in Atg16L1 mutant mice. However, the effects of Paneth cells need not be restricted to the ileum since active peptides from their granules can be detected in the distal colonic lumen (Mastroianni and Ouellette, 2009 ). Since it is unclear how diverse pathologies are related to one another in Crohn's disease patients, it will be important to address the relationship between Paneth cells, the microbiome, and the virome in the context HM mice infected with MNV CR6 for 7 days followed by additional 7 days of DSS treatment at which point intestines were harvested. The muscularis propria thickness in the region adjacent to the ano-rectal junction was quantified and normalized to the average of WT mice receiving isotype control antibodies (n R 6 mice/ condition, *p < 0.05, mean ± SEM).
(B) Number of lymphoid aggregates in the region adjacent to the ano-rectal junction from mice in (A) (*p < 0.001, mean ± SEM).
(C) Quantification of average villus height from mice in (A) normalized to the average of WT mice receiving isotype control antibodies (an average of 263 total villi from at least 5 mice/condition was measured, *p < 0.05, ***p < 0.001, mean ± SEM).
(D) WT and Atg16L1 HM mice were orally inoculated with MNV CR6 for 7 days and then given 2.5% DSS and broad spectrum antibiotics concurrently for another 7 days at which point intestines were harvested. The muscularis propria thickness was normalized to the average of uninfected WT mice treated with DSS from Figure 4D (n = 6 mice/ condition, *p < 0.05, mean ± SEM).
(E) Number of lymphoid aggregates from mice in (D) (***p < 0.001, mean ± SEM).
(F) Quantification of average villus height from mice in (D) normalized to the average of uninfected WT mice treated with DSS from Figure 5B (an average of 320 total villi from at least 5 mice/condition was measured, *p < 0.05, mean ± SEM). See also Figure S5 .
of the aberrant injury response dependent on the virus-plussusceptibility gene interaction in our model.
Disease Penetrance in Mouse Models of Mucosal Immunity
Based on our observations in Atg16L1 mutant mice, we speculate that other traits attributed to specific mutations are also dependent on viral infections. The presence of an infectious agent can lead to different experimental outcomes between laboratories. For example, experimental allergic encephalomyelitis correlates with mouse facility-specific pathogen exposure (Goverman et al., 1993) . Experimental discrepancies between facilities are particularly germane for models of intestinal disease since MNV is an enteric virus commonly detected in specific pathogen free facilities (Hsu et al., 2005; Pritchett-Corning et al., 2009; Goto et al., 2009 (Lencioni et al., 2008) . Thus, the effect that a particular pathogen has on the host cannot be generalized. Although we focus on a single virus and gene, multiple interactions may exist between different susceptibility genes and an array of commensals and pathogens. Much remains to be learned about the interactions between susceptibility genes and specific pathogens to understand what may be a general ''microbe plus susceptibility gene'' contribution to a range of complex diseases.
Understanding the Contributions of Genetic and Environmental Factors in Complex Diseases
Epidemiological studies have not identified a specific infectious cause for inflammatory bowel disease. Reported associations between disease risk and infectious gastroenteritis are correlative (Porter et al., 2008; Garcia Rodriguez et al., 2006; Gradel et al., 2009 ), but are of interest given our data since human noroviruses related to MNV cause human gastroenteritis (Mead et al., 1999) . Since many bacteria and viruses cause gastroenteritis, the infectious trigger of a complex disease need not be a single specific agent. Rather several agents that affect similar immunologic pathways can be involved. Interestingly, the Crohn's disease associated gene NOD2 may recognize viral RNA in addition to bacterial peptidoglycan (Sabbah et al., 2009; Shapira et al., 2009) , raising the possibility that a viral infection can interact with multiple susceptibility genes. Although Atg16L1 mutant mice do not display all pathology found in Crohn's disease patients, we have reproduced several disease hallmarks in a mouse with a mutation in a single susceptibility gene. It is commonly assumed that the failure to recreate the entirety of Crohn's disease in various mouse models is due to inherent differences between humans and mice. However, in the combinatorial view of complex disease supported by our results, reproducing full disease may require combinations of specific alleles of multiple genes with certain environmental agents. It is worth noting that not all Crohn's disease patients exhibit identical symptoms or pathologies, and the nature of Crohn's disease varies over time even within one individual. In addition, therapeutic interventions that improve conditions for some do not always alleviate disease in others. Therefore, complex diseases may represent a combinatorial confluence of pathologic responses, each with overlapping but nonidentical genetic and environmental causes and therefore therapeutic responses.
This paradigm has profound implications for how we view the relationship between genetic heterogeneity and phenotype in humans. We propose that studies examining associations between disease susceptibility and genetic variation should consider the history and current status of viral infections in the individuals. Similarly, studies examining the correlation between viral infections and disease would benefit from sorting individuals based on genetic background. If we can improve our knowledge in this area, the concept of personalized medicines may become closer to clinical application.
EXPERIMENTAL PROCEDURES Mice
Atg16L1
HM mice were described (Cadwell et al., 2008a) . The Atg16L1 HM line housed in a conventional barrier facility was rederived by embryo transfer into the enhanced facility with the following specialized features: all cages, bedding, chow, and water are autoclaved prior to use; access to breeding mice in this facility is restricted to specially trained personnel; and sentinel mice are routinely screened for common mouse pathogens including MNV. Mice were generated by mating heterozygotes for the gene trap mutagenized Atg16L1 locus. Progeny homozygous for the mutation and wild-type littermates aged 7-15 weeks were used in experiments.
Viruses
Generation of concentrated stocks was described (Chachu et al., 2008) . Twenty-five microliters of concentrated stocks (3 3 10 7 pfu) of MNV CR6
and CW3 was orally inoculated into mice. For virus quantification, total RNA was harvested per one stool pellet, 1 cm of intestine, or total mesenteric lymph nodes. qRT-PCR for MNV genome copy numbers was as described (Thackray et al., 2007) . For detection of virus in Paneth cells, $300 crypts from three mice/genotype were procured by laser capture microdissection (Extended Experimental Procedures) 7 days postinfection with MNV CR6. As a positive control, MNV was detected in whole gut RNA from similarly prepared tissue.
Statistical Analysis
Lysozyme distribution, muscle thickness, lymphoid aggregates, and villus height were analyzed by two-tailed unpaired t tests. Viral genome copies were analyzed with the nonparametric Mann-Whitney test. Analyses except for microarray data used GraphPad Prism (version 5.00).
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Microarray files have been deposited in Array Express with accession codes E-TABM-957 and E-TABM-958.
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